Sharmin Sultana

Sharmin SultanaSharmin Sultana

Education:

B.A. Hunter College (2021)

Current Position:

1st Year MSTP

1st Year Medical Student

Advisor:  

TBA

Graduate Program: 

TBA

Research Interests:

As an undergraduate, I characterized the venom cocktails and identified potential therapeutic candidates from venomous Terebridae snails. During my gap years, I investigated prognostic and predictive biomarkers to characterize the tumor microenvironment of primary melanoma and hepatocellular carcinoma. Through these research experiences, I became interested in exploring the biochemical pathways underlying neurological disorders, therapeutics discovery, and pain management.

Publications:

  • Bteich F, Desai K, Zhang C, Kaur A, Levy RA, Bioh L, Wang A, Sultana S, Kaubisch A, Kinkhabwala M, Bellemare S, Fidvi S, Kanmaniraja D, Berkenblit R, Moon JY, Adedimeji A, Tow CY, Saenger Y. (2024) Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States. J. Hepatocell. Carcinoma, 2024(11), 257-269. https://doi.org/10.2147/JHC.S436804
     
  • McDermott M, Cerullo AR, Parziale J, Achrak E, Sultana S, Ferd J, Samad S, Deng W, Braunschweig AB, Holford M. (2021). Advancing Discovery of Snail Mucins Function and Application. Front. Bioeng. Biotechnol., 9, 854. https://doi.org/10.3389/fbioe.2021.734023

Conference Posters/Presentations:

  • Espinoza G, Zhang C, Moon JY, Kenchappa DB, Abbruzzese M, Bioh L, Bracero YM, Sultana S, Singh A, Aung T, Krolewski JJ, Gartrell RD, Geskin LJ, Leung LW, Ferringer T, Chang R, Horst B, Nastiuk K, Saenger Y. “Immune biomarkers for recurrence in stage II and III melanoma to guide patient stratification.” Poster presented by Saenger at: American Association for Cancer Research (AACR) Annual Meeting 2024. 5-10 April 2024. San Diego, CA.
     
  • Qi X, Sultana S, McGuckin C, Remotti H, Wu H, Saenger Y, Liu Q. “Neutrophil Infiltration of Tumor Area Correlates with Non-Recurrence in Patients with Hepatocellular Carcinoma.” Poster presented by Qi at: United States and Canadian Academy of Pathology (USCAP) 112th Annual Meeting. 11-16 March 2023. New Orleans, LA.
     
  • Bteich F, Desai K, Zhang C, McGuckin C, Yan J, Sultana S, Leung L, Kaubisch A, Kinkhabwala M, Bellemare S, Adedimeji A, Tow C, Saenger Y. “Immunotherapy efficacy and tolerability in advanced hepatocellular carcinoma (HCC) in a diverse and underserved population in the United States - Importance of baseline liver function and screening.” Poster presented by Bteich at: Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting. 8-12 November 2022. Boston, MA.
     
  • Sultana S, Wang S, Cooper WR, McGuckin CR, Rakhade S, Tartaro MA, Gartrell RD, Nastiuk K, Rimm DL, Geskin LJ, Messina J, Horst B, Ferringer TC, Saenger Y. “Validation of CD8/CD68 Ratio as a Biomarker for Stage II-III Melanoma.” Poster presented by Saenger at: The 19th International Congress of the Society for Melanoma Research (SMR). 17-20 October 2022. Edinburgh, UK.
     
  • Sultana S, Napolitano T, Holford M. “Characterizing the Molecular Targets of Venom Peptides Using Peptide-HaloTag and Peptide-TurboID Fusions.” Poster presented at: Hunter College Undergraduate STEM Research Conference (UGSC). 6-7 May 2021. New York, NY.
     
  • Sultana S, Napolitano T, Holford M. “Identifying Venom Peptides with Therapeutic Potential Using VenomSeq Technology.” Poster presented at: American Medical Student Association Conference (AMSACon). 6-8 March 2021. Virtual.
     
  • Sultana S, Napolitano T, Holford M. “Application of VenomSeq Technology to Decipher the Putative Mechanism of Action and Molecular Targets of Venom Peptides.” Poster presented at: Annual Biomedical Research Conference for Minority Students (ABRCMS). 9-13 November 2020. Virtual.
     
  • Sultana S, Napolitano T, Holford M. “Application of VenomSeq Technology to Decipher the Putative Mechanism of Action and Molecular Targets of Venom Peptides.” Poster presented at: Mount Sinai Biomedical Research Symposium. 4 November 2020. Virtual.
     
  • Sultana S, Napolitano T, Holford M. “Application of VenomSeq Technology to Decipher the Putative Mechanism of Action and Molecular Targets of Venom Peptides.” Poster presented at: Hunter College Undergraduate STEM Research Conference (UGSC). 29 April 2020. New York, NY.
     
  • Sultana S, Napolitano T, Holford M. “Establishing a Method for Recombinant Expression of Disulfide-Rich Venom Peptides.” Poster presented at: Annual Biomedical Research Conference for Minority Students (ABRCMS). 13-16 November 2019. Anaheim, CA.
     
  • Sultana S, Samad S, Napolitano T, Holford M. “Establishing a Method for Recombinant Expression of Disulfide-Rich Venom Peptides.” Poster presented at: Hunter College Undergraduate STEM Research Conference (UGSC). 3 May 2019. New York, NY.